Slingshot members are tracking this event:

PUDFA date for KEYTRUDA in treating Relapsed or Refractory Classical Hodgkin Lymphoma set on March 15 2017

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
MRK Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Keytruda, Hodgkin Lymphoma